A study of a Klebsiella vaccine for healthy adults
Part of Immune system & allergy, Infections clinical trials.
This trial tests a new two-part vaccine (CHO-V08) to prevent Klebsiella pneumoniae infection. It looks at safety and immune response in healthy adults aged 18 to 50.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- Your BMI is between 18 and 30.
- You are generally healthy, with no serious medical conditions.
- You have not had a Klebsiella infection before.
- You are not pregnant and use effective birth control if needed.
- You have not received any other vaccines in the past month.
- You have no vaccine allergies or immune system problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a pneumococcal vaccine can help protect against a specific type of pneumonia bacteria. Researchers want to see if the vaccine can create antibodies that work against multiple strains.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
This study tests an experimental vaccine designed to protect against E. coli bacteria. It is for healthy adults aged 18 to 63 who want to help researchers see if the vaccine is safe and produces an immune response.
This early-phase study tests whether a new vaccine called V118E is safe and well-tolerated in healthy people. It is for adults who are in good health and have not recently had a pneumococcal infection.
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
This study tests a new pneumococcal vaccine to see if it is safe and triggers a good immune response. It may help protect you from infections like pneumonia, but you must not have had any pneumococcal vaccine since age 5.
Hear when a new Klebsiella Pneumoniae Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.